Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 206

1.

National antidepressant prescribing in children and adolescents with mental health disorders after an FDA boxed warning.

Mittal M, Harrison DL, Miller MJ, Brahm NC.

Res Social Adm Pharm. 2014 Sep-Oct;10(5):781-90. doi: 10.1016/j.sapharm.2013.11.001. Epub 2013 Nov 20.

PMID:
24355381
2.

Off-label prescribing patterns of antidepressants in children and adolescents.

Lee E, Teschemaker AR, Johann-Liang R, Bazemore G, Yoon M, Shim KS, Daniel M, Pittman J, Wutoh AK.

Pharmacoepidemiol Drug Saf. 2012 Feb;21(2):137-44. doi: 10.1002/pds.2145. Epub 2011 Apr 28.

PMID:
21538674
3.

Effects of Food and Drug Administration warnings on antidepressant use in a national sample.

Olfson M, Marcus SC, Druss BG.

Arch Gen Psychiatry. 2008 Jan;65(1):94-101. doi: 10.1001/archgenpsychiatry.2007.5.

PMID:
18180433
4.

Pediatric prescribing practices and the FDA Black-box warning on antidepressants.

Cheung A, Sacks D, Dewa CS, Pong J, Levitt A.

J Dev Behav Pediatr. 2008 Jun;29(3):213-5. doi: 10.1097/DBP.0b013e31817bd7c9.

PMID:
18550990
5.

Impact of publicity concerning pediatric suicidality data on physician practice patterns in the United States.

Nemeroff CB, Kalali A, Keller MB, Charney DS, Lenderts SE, Cascade EF, Stephenson H, Schatzberg AF.

Arch Gen Psychiatry. 2007 Apr;64(4):466-72.

PMID:
17404123
6.
7.

Antidepressant drug therapy and suicide in severely depressed children and adults: A case-control study.

Olfson M, Marcus SC, Shaffer D.

Arch Gen Psychiatry. 2006 Aug;63(8):865-72.

PMID:
16894062
8.

National trends in prescribing antidepressants before and after an FDA advisory on suicidality risk in youths.

Chen SY, Toh S.

Psychiatr Serv. 2011 Jul;62(7):727-33. doi: 10.1176/ps.62.7.pss6207_0727.

PMID:
21724784
9.

Effect of regulatory warnings on antidepressant prescription rates, use of health services and outcomes among children, adolescents and young adults.

Katz LY, Kozyrskyj AL, Prior HJ, Enns MW, Cox BJ, Sareen J.

CMAJ. 2008 Apr 8;178(8):1005-11. doi: 10.1503/cmaj.071265. Erratum in: CMAJ. 2008 May 20;178(11):1466.

10.

Persisting decline in depression treatment after FDA warnings.

Libby AM, Orton HD, Valuck RJ.

Arch Gen Psychiatry. 2009 Jun;66(6):633-9. doi: 10.1001/archgenpsychiatry.2009.46.

PMID:
19487628
11.

Patterns and determinants of antipsychotic prescribing in children and adolescents, 2003-2004.

Aparasu RR, Bhatara V.

Curr Med Res Opin. 2007 Jan;23(1):49-56.

PMID:
17257465
12.

Antidepressants use in pediatric populations.

Gören JL.

Expert Opin Drug Saf. 2008 May;7(3):223-5. doi: 10.1517/14740338.7.3.223 .

PMID:
18462180
13.

Antidepressant Regulatory Warnings, Prescription Patterns, Suicidality and Other Aggressive Behaviors in Major Depressive Disorder and Anxiety Disorders.

Gupta S, Gersing KR, Erkanli A, Burt T.

Psychiatr Q. 2016 Jun;87(2):329-42. doi: 10.1007/s11126-015-9389-8.

PMID:
26303613
14.

Antidepressant prescribing practices of outpatient psychiatrists.

Olfson M, Marcus SC, Pincus HA, Zito JM, Thompson JW, Zarin DA.

Arch Gen Psychiatry. 1998 Apr;55(4):310-6.

PMID:
9554426
15.

Antidepressant prescribing practices for the treatment of children and adolescents.

Bhatia SK, Rezac AJ, Vitiello B, Sitorius MA, Buehler BA, Kratochvil CJ.

J Child Adolesc Psychopharmacol. 2008 Feb;18(1):70-80. doi: 10.1089/cap.2007.0049.

PMID:
18294090
16.

Depression treatment during outpatient visits by U.S. children and adolescents.

Ma J, Lee KV, Stafford RS.

J Adolesc Health. 2005 Dec;37(6):434-42.

PMID:
16310120
17.

Atomoxetine use during a period of FDA actions.

Du DT, Zhou EH, Goldsmith J, Nardinelli C, Hammad TA.

Med Care. 2012 Nov;50(11):987-92. doi: 10.1097/MLR.0b013e31826c86f1.

PMID:
23047788
18.

Sociological influences on antidepressant prescribing.

Sleath B, Shih YC.

Soc Sci Med. 2003 Mar;56(6):1335-44.

PMID:
12600369
19.

National trends in psychotropic medication polypharmacy in office-based psychiatry.

Mojtabai R, Olfson M.

Arch Gen Psychiatry. 2010 Jan;67(1):26-36. doi: 10.1001/archgenpsychiatry.2009.175.

PMID:
20048220

Supplemental Content

Support Center